The U.S. Food and Drug Administration has approved the OphtaCath lacrimal duct balloon catheter from FCI Ophthalmics, according to a press release. The OphtaCath achieves dilation of the lacrimal duct and treats the symptoms of epiphora, according to the release.
Help employers find you! Check out all the jobs and post your resume.
